Moderna Sees Positive Results For Combined Flu-COVID Vaccine

Vaccine maker Moderna has announced positive results of a trial for combined COVID-19 and influenza vaccine, a move toward making more vaccination options available for future virus seasons. For the upcoming fall-winter vaccination campaign, Moderna has submitted an FDA application for a monovalent vaccine against COVID-19; more patients will likely also have access to vaccination against respiratory syncytial virus. Moderna announced the results of its phase 3 trial in a statement Monday (June 10) . The company said it is...